ArticlePloS one2026
Integrating text mining and knowledge graph to enhance biopharmaceutical process optimization.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
To guarantee consistent quality of therapeutic proteins, the relationship between manufacturing process parameters and glycosylation profiles must be investigated and understood. The most important manufacturing step to investigate is the cell culture unit operation, where glycoprotein structure is highly dependent on raw materials, cell line genetics, and process control ranges. Because of the critical role glycosylation plays in certain drug mechanisms of action, the relationship between specific process inputs and glycosylation have been documented extensively. However, despite the extensive body of published work, general relationships between different cell culture conditions and glycosylation profiles remain fragmented across diverse studies, hindering systematic analysis and data-driven decision-making. To better elucidate these general relationships from published research, we introduce an innovative framework that leverages text mining and knowledge graph technologies to automatically extract, integrate, and visualize complex relationships from scientific literature, enabling actionable insights for biopharmaceutical process (bioprocess) development. Our methodology centers on the design and development of a specialized text-mining pipeline to extract and quantify relationships between cell culture conditions (raw materials, cell line genetics, and process control ranges) and glycosylation profiles from unstructured scientific literature. To enhance precision, we implement a dual normalization strategy: 1) dictionary-based concept standardization to reconcile term variants, and 2) ontological classification to organize entities into hierarchically structured categories. These curated relationships are then systematically integrated into a knowledge graph, which not only captures direct parameter-outcome associations but also reveals higher-order indirect connection through graph, providing a comprehensive view of bioprocess interactions. We present an intuitive web-based interface that enables researchers to dynamically explore and visualize complex bioprocess relationships through interactive queries. The system demonstrates robust performance with an 88% F1-score in relation extraction, effectively revealing hidden relationships between process parameters and glycan attributes. By combining scalable knowledge graph technology with interpretable analytics, our solution empowers pharmaceutical researchers to optimize therapeutic glycan profiles and accelerate manufacturing process development. This advancement represents a significant step forward in data-driven bioprocess optimization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.